Kevin J. Tracey is President and CEO of The Feinstein Institute for Medical Research, and Professor of Molecular Medicine and Neurosurgery at the Zucker School of Medicine. He is a leader in the study of the molecular basis of inflammation. He and his colleagues identified the neural mechanism for controlling the immunological responses to infection and injury, and developed devices to replace anti-inflammatory drugs in clinical trials of rheumatoid arthritis, a new field termed bioelectronic medicine. The recipient of numerous awards and honors, including an honorary degree from the Karolinska Institute, Dr. Tracey is a Fellow in the American Association for the Advancement of Science, and a member in the American Society for Clinical Investigation, and the Association of American Physicians. He is co-founder and Councilor of the Global Sepsis Alliance.
Professor Tracey graduated summa cum laude from Boston College, majoring in chemistry, and received his MD from Boston University. He trained in neurosurgery at the New York Hospital/Cornell University Medical Center, and was guest investigator at The Rockefeller University. Since 1992 he has directed the Laboratory of Biomedical Science in Manhasset, NY, where in 2005 he was appointed President of the Feinstein Institute. Dr. Tracey delivers lectures nationally and internationally on inflammation, sepsis, the neuroscience of immunity, and bioelectronic medicine. Dr. Tracey is the author of Fatal Sequence (Dana Press), and his scientific publications include more than 320 papers.